Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Kinamed Inc. currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are being handled by 2 distinct examiners working in 2 distinct art units, which indicates that the company's active patent applications are being reviewed in separate administrative and technical environments. This distribution requires a strategy that can account for the different standards and examiner behaviors present across two different sections of the patent office.
The busiest examiner for the portfolio is KOTIS, JOSHUA G, who is currently managing 1 busiest examiner pending office action. Since there are 2 pending office actions and 2 distinct examiners, KOTIS, JOSHUA G is responsible for a portion of the company's current prosecution workload. The other portion is managed by the second distinct examiner in the second of the 2 distinct art units. This split means that the company's success in the Medical Devices & Mechanical Engineering sector is currently dependent on two independent review processes.
The involvement of 2 distinct art units for only 2 pending office actions suggests that Kinamed Inc. is pursuing patents in diverse sub-fields of Medical Devices & Mechanical Engineering. Practitioners must be prepared to address the specific feedback from KOTIS, JOSHUA G for the 1 busiest examiner pending action under his review, while also managing the requirements of the other distinct examiner. This ratio of actions to examiners and art units underscores the varied nature of the company's current prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOTIS, JOSHUA G | 1 | 74.2% | +57.0% |
| PRICE, NATHAN R | 1 | 53.4% | +38.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18200703 | MEDICAL IMPLANTS WITH NANO SURFACES | KOTIS, JOSHUA G | 38d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18200703 | MEDICAL IMPLANTS WITH NANO SURFACES | KOTIS, JOSHUA G | 38d overdue |
| 17875745 | BONE PREPARATION METHOD FOR ENHANCING OSSEOINTEGRATION | PRICE, NATHAN R | — |
| Art Unit | Apps |
|---|---|
| 3731 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18200703 | MEDICAL IMPLANTS WITH NANO SURFACES | KOTIS, JOSHUA G | 3731 | §103§112 | Final Rejection | 38d overdue | Pending | May 23, 2023 |
| 17875745 | BONE PREPARATION METHOD FOR ENHANCING OSSEOINTEGRATION | PRICE, NATHAN R | 3783 | §103 | Final Rejection | — | Pending | Jul 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial